|
|
Volumn , Issue , 2014, Pages e504-e510
|
|
Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
TUMOR PROTEIN;
ANIMAL;
BIOLOGY;
DRUG DESIGN;
GENETICS;
HIGH THROUGHPUT SCREENING;
HUMAN;
MASS SPECTROMETRY;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
NEOPLASMS;
PATHOLOGY;
PHOSPHORYLATION;
PREDICTIVE VALUE;
PROCEDURES;
PROGNOSIS;
PROTEIN PROTEIN INTERACTION;
PROTEOMICS;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
COMPUTATIONAL BIOLOGY;
DRUG DESIGN;
HIGH-THROUGHPUT SCREENING ASSAYS;
HUMANS;
MASS SPECTROMETRY;
MOLECULAR TARGETED THERAPY;
NEOPLASM PROTEINS;
NEOPLASMS;
PHOSPHORYLATION;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
PROTEIN INTERACTION MAPS;
PROTEOMICS;
SIGNAL TRANSDUCTION;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84918582701
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.e504 Document Type: Review |
|
Times cited : (39)
|
|
References (0)
|